Alameda, CA, United States of America

Leslie Carol Hodges Gallagher

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):

Title: Innovations by Leslie Carol Hodges Gallagher: A Look at Her Patents and Contributions

Introduction: Leslie Carol Hodges Gallagher, an innovative inventor based in Alameda, California, holds a significant patent in the field of pharmaceuticals. Her research and development work have led to advancements in compounds that exhibit strong anti-estrogenic activity, contributing to the progress in treatments for hormone-related conditions.

Latest Patents: Gallagher's sole patent focuses on benzopyran compounds, specifically OP-1038 and OP-1074. OP-1038, which is identified as 3-(4-hydroxyphenyl)-4-methyl-2-(4-{2-[(3R)-3-methylpyrrolidin-1-yl]ethoxy}phenyl)-2H-chromen-7-ol, along with OP-1074, (2S)-3-(4-hydroxyphenyl)-4-methyl-2-(4-{2-[(3R)-3-methylpyrrolidin-1-yl]ethoxy}phenyl)-2H-chromen-7-ol, showcases distinct anti-estrogen properties. OP-1074, in particular, has demonstrated efficacy as a pure anti-estrogen in agonistic conditions and as a complete anti-estrogen in antagonistic modes. These compounds have the potential to address various medical conditions moderated by estrogen receptors in mammals, including humans.

Career Highlights: Leslie currently works with Olema Pharmaceuticals, Inc., where she continues to drive innovations in pharmaceutical research. Her work predominantly involves exploring novel compositions that leverage estrogen receptor modulation for therapeutic applications.

Collaborations: In her journey, Gallagher has collaborated with notable colleagues such as Peter J. Kushner and David C. Myles. These partnerships have fostered a productive environment for scientific exploration and developmental breakthroughs, enhancing the potential of their collective innovations.

Conclusion: Leslie Carol Hodges Gallagher exemplifies the spirit of innovation within the pharmaceutical landscape. Her pioneering work in benzopyran compounds not only showcases her inventive prowess but also heralds advancements in treatments that could impact countless lives around the globe. Through her contributions and collaborations, Gallagher continues to shape the future of medical solutions and the science of healing.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…